Haznedaroglu, I. (2013). MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML). Mediterranean Journal of Hematology and Infectious Diseases, 6(1), e2014009. https://doi.org/10.4084/mjhid.2014.009